Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis
Clinical trial NCT07400965 · RECRUITING
Trial details
- NCT number
- NCT07400965
- Sponsor
- Glaukos Corporation
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-05
- Primary completion
- 2026-09-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.